Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Initial Assessment of Safety and Performance of the Sphere-9™ Catheter and System for Mapping and Ablation of Atrial and Ventricular Arrhythmias

NCT04211441 is registered in ClinicalTrials.gov with Medtronic Cardiac Ablation Solutions as lead sponsor.

NCT NCT04211441
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04211441 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Initial Assessment of Safety and Performance of the Sphere-9™ Catheter and System for Mapping and Ablation of Atrial and Ventricular Arrhythmias
Lead sponsor
Medtronic Cardiac Ablation Solutions
Phase
Not applicable
Overall status
Completed
Start date
June 1, 2018
Completion date
September 18, 2020
Enrollment
74 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, atrial flutter, ventricular tachycardia